Reprogramming the cancer microenvironment with vaccine-based therapy

Reprogramming the cancer microenvironment with vaccine-based therapy

Prof Lei Zheng speaks with ecancer and his research into vaccine therapies to treat pancreatic cancer. Pancreatic cancer is notoriously resistant to many treatments, including checkpoint inhibitors. Prof Zheng reports that using combined vaccine alongside anti-PD1 therapies primes the tumour microenvironment, increasing sensitivity and drug uptake.